Clinical trial

High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer

NCT00003284

Study summary

ClinicalTrials.gov

High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

7 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BIOLOGICAL · Unmapped registry intervention filgrastim Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record carboplatin Normalized identity: carboplatin View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record etoposide Normalized identity: etoposide View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record ifosfamide Normalized identity: ifosfamide View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record paclitaxel Normalized identity: paclitaxel View linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention peripheral blood stem cell transplantation Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention radiation therapy Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date1998-01-01

PhasePHASE2

Conditions

Lung Cancerverified · MONDO: lung cancer

Interventions

filgrastimBIOLOGICAL

carboplatinDRUG · verified · RxNorm: carboplatin

etoposideDRUG · verified · RxNorm: etoposide

ifosfamideDRUG · verified · RxNorm: ifosfamide

paclitaxelDRUG · verified · RxNorm: paclitaxel

peripheral blood stem cell transplantationPROCEDURE

radiation therapyRADIATION

Sponsors & collaborators

Herbert Irving Comprehensive Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00003284 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.